Joseph Monahan - 01 Mar 2023 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role: Chief Scientific Officer
Signature: /s/ Mark Ballantyne, Attorney-in-fact
Issuer symbol: ACRS
Transactions as of: 01 Mar 2023
Net transactions value: -$385,639
Form type: 4
Filing time: 03 Mar 2023, 19:12:48 UTC
Previous filing: 17 Feb 2023
Next filing: 22 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACRS	Common Stock	Options Exercise		+13,750	+15%		105,136	01 Mar 2023	Direct	F1
transaction	ACRS	Common Stock	Options Exercise		+50,000	+48%		155,136	01 Mar 2023	Direct	F1
transaction	ACRS	Common Stock	Options Exercise		+10,925	+7%		166,061	01 Mar 2023	Direct	F1
transaction	ACRS	Common Stock	Sale	$183,024	-14,800	-8.9%	$12.37	151,261	02 Mar 2023	Direct	F2, F3
transaction	ACRS	Common Stock	Options Exercise		+12,500	+8.3%		163,761	02 Mar 2023	Direct	F1
transaction	ACRS	Common Stock	Sale	$202,615	-16,037	-9.8%	$12.63	147,724	03 Mar 2023	Direct	F4, F5
holding	ACRS	Common Stock						193	01 Mar 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACRS	Restricted Stock Units	Options Exercise	$0	-13,750	-100%	$0.000000^*	0	01 Mar 2023	Common Stock	13,750		Direct	F1, F6
transaction	ACRS	Restricted Stock Units	Options Exercise	$0	-50,000	-33%	$0.000000	100,000	01 Mar 2023	Common Stock	50,000		Direct	F1, F7
transaction	ACRS	Restricted Stock Units	Options Exercise	$0	-10,925	-25%	$0.000000	32,775	01 Mar 2023	Common Stock	10,925		Direct	F1, F8
transaction	ACRS	Restricted Stock Units	Options Exercise	$0	-12,500	-50%	$0.000000	12,500	02 Mar 2023	Common Stock	12,500		Direct	F1, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
F2	Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 1, 2023 pursuant to preexisting sell-to-cover elections.
F3	The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $11.90 to $12.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 1, 2023 and March 2, 2023 pursuant to preexisting sell-to-cover elections.
F5	The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $12.43 to $12.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6	The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.
F7	The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.
F8	The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2023, subject to the Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.
F9	The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.